ImageneBio (IMA) Other financing activities (2020 - 2025)

ImageneBio has disclosed Other financing activities across 5 years of filings, most recently posting $45000.0 for Q1 2025.

• In Q1 2025, Other financing activities changed N/A year-over-year to $45000.0; the TTM figure through Sep 2025 stood at $45000.0 (changed N/A YoY), while the FY2023 annual figure was $136000.0, down 87.58% from the prior year.
• Other financing activities came in at $45000.0 for Q1 2025 at ImageneBio, up from $15000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $132.4 million in Q1 2021 to a low of -$1.1 million in Q2 2021.
• Average Other financing activities over 4 years is $16.6 million, with a median of $34500.0 recorded in 2022.
• Year-over-year, Other financing activities surged 630528.57% in 2021 and tumbled 99.63% in 2022.
• Over 4 years, Other financing activities stood at -$1.1 million in 2021, then surged by 100.09% to $1000.0 in 2022, then soared by 1400.0% to $15000.0 in 2023, then soared by 200.0% to $45000.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $45000.0 in Q1 2025, $15000.0 in Q3 2023, and $1000.0 in Q4 2022.